Get Started
Multiple Sclerosis Curricula
Step 1
These independent CME activities are supported by educational grants from Biogen MA, Inc.,Celgene Corporation, Genzyme, a Sanofi Company and Novartis Pharmaceuticals Corporation.



      Neurology Mastery in
   Multiple Sclerosis
  1. Course List
CME/CE Information

Target Audience

This series of activities is designed for neurologists, primary care physicians, nurses, nurse practitioners, and pharmacists involved in the screening and treatment of patients with multiple sclerosis.

Activity Goal

The goal of this program is to provide new information based on breaking medical news, new data presented at medical meetings, and an interactive case on current management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple sclerosis.

Learning Objective (s)

  • Evaluate criteria that have been developed to assess treatment response in multiple sclerosis and delineate how these criteria can be used to risk-stratify patients in clinical practice.
  • Formulate personalized treatment regimens that improve patient outcomes based on an understanding of the mechanism of action, efficacy, and safety profiles of current and emerging treatment options.

Instructions


To obtain credit:

  1. Read or listen to each activity carefully.
  2. Complete/submit each posttest and evaluation.
  3. Instantly access and print out your certificate.

There is no fee for this activity.

CONTRACT FOR MUTUAL RESPONSIBILITY IN

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here.
Disclosure Information

James D. Bowen, MD received financial support for research activities from Acorda Therapeutics, Alexion, Allergan, Biogen, EMD Serono Inc, Genzyme, a Sanofi Company, Genentech, GlaxoSmithKline, Novartis, Opexa, Osmotica, Roche, sanofi-aventis U.S. LLC, and Xenoport; has received consulting fees from Acorda Therapeutics, Biogen, EMD Serono Inc, Genzyme, a Sanofi Company, Genentech, Novartis, and Teva Neuroscience; and has received honoraria from Acorda Therapeutics, Biogen, EMD Serono Inc, Genentech, Novartis, Pfizer Inc, and Teva Neuroscience.

Enrique Alvarez, MD, PhD, MSCI has received consulting fees from Biogen Idec, Genentech, Genzyme, Novartis Pharmaceuticals Corporation, and Teva Neuroscience and has conducted contracted research for Acorda, Biogen Idec, Genentech, and Novartis Pharmaceuticals Corporation.

Maria Houtchens, MD has received honoraria from Genzyme, a Sanofi Company and Teva Pharmaceuticals; has received consulting fees from Biogen Inc., Genzyme, a Sanofi Company, and Teva Pharmaceuticals; and conducted contracted research for Biogen Inc., and Genzyme, a Sanofi Company.

Jacqueline A. Nicholas, MD, MPH has received honoraria from Biogen Idec, Genentech, Inc., Genzyme, a Sanofi Company and Novartis Pharmaceuticals Corporation; and conducted contracted research for Biogen Idec, Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Bardia Nourbakhsh, MD, MAS has no relevant relationships to disclose.

John A. Schafer, MD, FAAN has received honoraria from Acorda Therapeutics, Biogen-Idec, EMD-Serono, Genentech, Inc., Genzyme Corporation, Novartis Pharmaceuticals Corporation, and TEVA Neuroscience; and has conducted contract research for Bayer AG, Biogen-Idec, Genenctech, Inc., Mallinckrodt Pharmaceuticals, Novartis Pharmaceutcials Corporation, and TEVA Pharmaceuticals.

Bianca Weinstock-Guttman, MD has received honoraria from Biogen Idec, Genentech, Inc., Novartis Pharmaceuticals Corporation, Sanofi, and Teva Pharmaceuticals; received consulting fees from Biogen Idec, Takeda, and Teva Pharmaceuticals; and conducted contracted research for Biogen Idec, EMD Serono, Novartis Pharmaceuticals Corporation, and Sanofi.

Peer Reviewer has disclosed no relevant relationships.

Projects In Knowledge's staff members have disclosed no relevant relationships.

These activities may contain discussions of unlabeled/unapproved uses of drugs or devices. Specific product disclosure will be forthcoming in each activity.

The opinions expressed in these activities are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This activity is provided solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

These independent CME activities are supported by educational grants from Biogen MA, Inc.,Celgene Corporation, Genzyme, a Sanofi Company and Novartis Pharmaceuticals Corporation.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

2299